Topics

Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 10, Status: Authorised

08:50 EST 8 Nov 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 10, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 10, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 10, Status: Authorised"

Quick Search